![The CA19-9 and Sialyl-TRA Antigens Define Separate Subpopulations of Pancreatic Cancer Cells | Scientific Reports The CA19-9 and Sialyl-TRA Antigens Define Separate Subpopulations of Pancreatic Cancer Cells | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-017-04164-z/MediaObjects/41598_2017_4164_Fig1_HTML.jpg)
The CA19-9 and Sialyl-TRA Antigens Define Separate Subpopulations of Pancreatic Cancer Cells | Scientific Reports
![IJMS | Free Full-Text | CA 19-9 Pancreatic Tumor Marker Fluorescence Immunosensing Detection via Immobilized Carbon Quantum Dots Conjugated Gold Nanocomposite IJMS | Free Full-Text | CA 19-9 Pancreatic Tumor Marker Fluorescence Immunosensing Detection via Immobilized Carbon Quantum Dots Conjugated Gold Nanocomposite](https://pub.mdpi-res.com/ijms/ijms-19-01162/article_deploy/html/images/ijms-19-01162-ag.png?1570011465)
IJMS | Free Full-Text | CA 19-9 Pancreatic Tumor Marker Fluorescence Immunosensing Detection via Immobilized Carbon Quantum Dots Conjugated Gold Nanocomposite
![CA19.9 in differentiating benign and malignant obstructive jaundice : Azam, Mohammad Golam, Bhuyian, Rokanuzzaman: Amazon.co.uk: Books CA19.9 in differentiating benign and malignant obstructive jaundice : Azam, Mohammad Golam, Bhuyian, Rokanuzzaman: Amazon.co.uk: Books](https://m.media-amazon.com/images/I/41Et4QDlFAL._SR600%2C315_PIWhiteStrip%2CBottomLeft%2C0%2C35_SCLZZZZZZZ_FMpng_BG255%2C255%2C255.jpg)
CA19.9 in differentiating benign and malignant obstructive jaundice : Azam, Mohammad Golam, Bhuyian, Rokanuzzaman: Amazon.co.uk: Books
![Introduction and overview of CA19-9 CA19-9 is a tumour associated antigen found in the blood serum. CA 19-9 is also known as the Sialylated Lewis- antigen. - ppt download Introduction and overview of CA19-9 CA19-9 is a tumour associated antigen found in the blood serum. CA 19-9 is also known as the Sialylated Lewis- antigen. - ppt download](https://slideplayer.com/10165346/34/images/slide_1.jpg)
Introduction and overview of CA19-9 CA19-9 is a tumour associated antigen found in the blood serum. CA 19-9 is also known as the Sialylated Lewis- antigen. - ppt download
![Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-65720-8/MediaObjects/41598_2020_65720_Fig1_HTML.png)
Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports
![Cancers | Free Full-Text | Duration of Reduced CA19-9 Levels Is a Better Prognostic Factor Than Its Rate of Reduction for Unresectable Locally Advanced Pancreatic Cancer Cancers | Free Full-Text | Duration of Reduced CA19-9 Levels Is a Better Prognostic Factor Than Its Rate of Reduction for Unresectable Locally Advanced Pancreatic Cancer](https://pub.mdpi-res.com/cancers/cancers-13-04224/article_deploy/html/images/cancers-13-04224-g001-550.jpg?1629630402)
Cancers | Free Full-Text | Duration of Reduced CA19-9 Levels Is a Better Prognostic Factor Than Its Rate of Reduction for Unresectable Locally Advanced Pancreatic Cancer
![CA19.9 in differentiating benign and malignant obstructive jaundice : Azam, Mohammad Golam, Bhuyian, Rokanuzzaman: Amazon.co.uk: Books CA19.9 in differentiating benign and malignant obstructive jaundice : Azam, Mohammad Golam, Bhuyian, Rokanuzzaman: Amazon.co.uk: Books](https://m.media-amazon.com/images/I/815ImDy8hmL._AC_UF894,1000_QL80_.jpg)
CA19.9 in differentiating benign and malignant obstructive jaundice : Azam, Mohammad Golam, Bhuyian, Rokanuzzaman: Amazon.co.uk: Books
![Combined use of CEMIP and CA 19-9 enhances diagnostic accuracy for pancreatic cancer | Scientific Reports Combined use of CEMIP and CA 19-9 enhances diagnostic accuracy for pancreatic cancer | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-21823-x/MediaObjects/41598_2018_21823_Fig1_HTML.jpg)
Combined use of CEMIP and CA 19-9 enhances diagnostic accuracy for pancreatic cancer | Scientific Reports
![Cancers | Free Full-Text | The Diagnostic Value of the CA19-9 and Bilirubin Ratio in Patients with Pancreatic Cancer, Distal Bile Duct Cancer and Benign Periampullary Diseases, a Novel Approach Cancers | Free Full-Text | The Diagnostic Value of the CA19-9 and Bilirubin Ratio in Patients with Pancreatic Cancer, Distal Bile Duct Cancer and Benign Periampullary Diseases, a Novel Approach](https://pub.mdpi-res.com/cancers/cancers-14-00344/article_deploy/html/images/cancers-14-00344-g001.png?1642579007)
Cancers | Free Full-Text | The Diagnostic Value of the CA19-9 and Bilirubin Ratio in Patients with Pancreatic Cancer, Distal Bile Duct Cancer and Benign Periampullary Diseases, a Novel Approach
![Nutrients | Free Full-Text | The Association of Carbohydrate Antigen (CA) 19 -9 Levels and Low Skeletal Muscle Mass in Healthy Adults Nutrients | Free Full-Text | The Association of Carbohydrate Antigen (CA) 19 -9 Levels and Low Skeletal Muscle Mass in Healthy Adults](https://www.mdpi.com/nutrients/nutrients-15-03394/article_deploy/html/images/nutrients-15-03394-g001-550.jpg)
Nutrients | Free Full-Text | The Association of Carbohydrate Antigen (CA) 19 -9 Levels and Low Skeletal Muscle Mass in Healthy Adults
![CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial - The Lancet Oncology CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial - The Lancet Oncology](https://www.thelancet.com/cms/attachment/2001025641/2003896921/gr1.gif)
CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial - The Lancet Oncology
![Cancers | Free Full-Text | Complementary Use of Carbohydrate Antigens Lewis a, Lewis b, and Sialyl-Lewis a (CA19.9 Epitope) in Gastrointestinal Cancers: Biological Rationale towards a Personalized Clinical Application Cancers | Free Full-Text | Complementary Use of Carbohydrate Antigens Lewis a, Lewis b, and Sialyl-Lewis a (CA19.9 Epitope) in Gastrointestinal Cancers: Biological Rationale towards a Personalized Clinical Application](https://www.mdpi.com/cancers/cancers-12-01509/article_deploy/html/images/cancers-12-01509-g002-550.jpg)
Cancers | Free Full-Text | Complementary Use of Carbohydrate Antigens Lewis a, Lewis b, and Sialyl-Lewis a (CA19.9 Epitope) in Gastrointestinal Cancers: Biological Rationale towards a Personalized Clinical Application
![Frontiers | Fucosylated Antigens in Cancer: An Alliance toward Tumor Progression, Metastasis, and Resistance to Chemotherapy Frontiers | Fucosylated Antigens in Cancer: An Alliance toward Tumor Progression, Metastasis, and Resistance to Chemotherapy](https://www.frontiersin.org/files/Articles/335649/fonc-08-00039-HTML-r1/image_m/fonc-08-00039-g001.jpg)
Frontiers | Fucosylated Antigens in Cancer: An Alliance toward Tumor Progression, Metastasis, and Resistance to Chemotherapy
![Figure 1 from Reference values and biological variation for tumor marker CA 19-9 in serum for different Lewis and secretor genotypes and evaluation of secretor and Lewis genotyping in a Caucasian population. Figure 1 from Reference values and biological variation for tumor marker CA 19-9 in serum for different Lewis and secretor genotypes and evaluation of secretor and Lewis genotyping in a Caucasian population.](https://d3i71xaburhd42.cloudfront.net/bb127959fd840127d322eb4c0f3133e4069e5c6a/2-Figure1-1.png)